The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
Erratum to "Survey on Plasmapheresis Practices in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis: Insights From Two Clinical Case Studies" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1292-1295]. [PDF]
Mousseaux C +3 more
europepmc +1 more source
Corrigendum to "Butyric acid-based products, alone or in combination with hydroxy-selenomethionine, improve performance of laying hens in post-peak period by modulating their antioxidant, metabolic and immune status" [Poultry Science Volume 104, Issue 4, April 2025, 104840]. [PDF]
Xia Z +9 more
europepmc +1 more source
Erratum to 'Illustrated State-of-the-Art Capsules of the ISTH 2024 Congress' [Research and Practice in Thrombosis and Haemostasis Volume 8, Issue 4, May 2024, 102432]. [PDF]
Ward C +34 more
europepmc +1 more source

